Kelyniam Global Announces Q2 2026 Financial Results

CANTON, CT / ACCESS Newswire / August 11, 2026 / Kelyniam Global (OTCID:KLYG), a leader in custom cranial implants, today reported its financial results for the six months ended June 30, 2026. The company delivered excellent performance, with strong revenue growth and a clear improvement in profitability.

Financial Highlights for the Six Months Ended June 30, 2026 vs. 2025 * Total revenue reached $1,904,547, up 39.6% from $1,364,432 in the prior-year period. * Gross profit increased 41.5% to $1,543,834, compared with $1,090,691 a year earlier. * Income from operations was $177,970, reversing an operating loss of $(59,869) in the same period of 2025. * EBITDA rose to $185,287 from a loss of $(52,474) in the prior-year period.